NordicRWE
NordicRWE is a Real-world Evidence (RWE) start-up company leveraging the unique Nordic health data infrastructure to accelerate data-driven drug development and lifecycle processes. The company provides crucial insights across the drug development cycle, supporting development, regulatory approvals, access, and long-term surveillance. NordicRWE specializes in innovative RWE applications such as external control arms for oncology clinical trials and drug signal detection using machine learning and advanced biostatistics. Their technology-driven approach includes interactive dashboards and synthetic data generation, serving international biopharma clients with full-service RWE research collaborations. The company is supported by public research grants and collaborates with national biobank infrastructures, positioning it as a key player in RWE-supported drug R&D with a strong scientific and commercial team based in Norway.
NordicRWE
NordicRWE is a Real-world Evidence (RWE) start-up company leveraging the unique Nordic health data infrastructure to accelerate data-driven drug development and lifecycle processes. The company provides crucial insights across the drug development cycle, supporting development, regulatory approvals, access, and long-term surveillance. NordicRWE specializes in innovative RWE applications such as external control arms for oncology clinical trials and drug signal detection using machine learning and advanced biostatistics. Their technology-driven approach includes interactive dashboards and synthetic data generation, serving international biopharma clients with full-service RWE research collaborations. The company is supported by public research grants and collaborates with national biobank infrastructures, positioning it as a key player in RWE-supported drug R&D with a strong scientific and commercial team based in Norway.